Overview
Abstract
The Automated Cell, Compound and Environment Screening System (ACCESS) was developed as an automated platform for chemogenomic research. In S. cerevisiae a number of genomic screens rely on the modulation of gene dose to determine the mode of action of bioactive compounds or the effects of environmental/compound perturbations. These and other phenotypic experiments have been shown to benefit from high-resolution growth curves and a highly automated controlled environment system that enables a wide range of multi-well assays than can be run over many days without any manual intervention. Furthermore precise control of drug dosing, timing of drug exposure and precise timing of cell harvesting at specific generation times is important for optimal results. Some of these benefits include the ability to derive fine distinctions between growth rates of mutant strains [1] and the discovery of novel compounds and drug targets [2]. The automation has also enabled large scale screening projects with over 100,000 unique compounds screened to date including a thousand genome-wide screens [3]. The ACCESS system also has a diverse set of software tools to enable users to set-up, run, annotate and evaluate complex screens with minimal training.
[1] Deutschbauer, AM, Jaramillo, DF, Proctor, M, Kumm, J, Hillenmeyer, ME, Davis, RW, Nislow, C, and Giaever, G. (2005). Mechanisms of haploinsufficiency revealed by genome-wide profiling in yeast. Genetics 169, 1915-25.
[2] Hoon, S, Smith, AM, Wallace, IM, Suresh, S, Miranda, M, Fung, E, Proctor, M, Shokat, KM, Zhang, C, Davis, RW, Giaever, G, St Onge, RP, and Nislow, C. (2008). An integrated platform of genomic assays reveals small-molecule bioactivities. Nat Chem Biol 4, 498-506.
[3] Hillenmeyer, ME, Fung, E, Wildenhain, J, Pierce, SE, Hoon, S, Lee, W, Proctor, M, St Onge, RP, Tyers, M, Koller, D, Altman, RB, Davis, RW, Nislow, C, and Giaever, G. (2008). The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 320, 362-5.
.